|
NHSL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.83297821365613E-12 |
| Normal-vs-Stage2 |
3.849800478406E-10 |
| Normal-vs-Stage3 |
1.03206332369155E-12 |
| Normal-vs-Stage4 |
1.46919999499673E-08 |
| Stage1-vs-Stage2 |
6.088000E-01 |
| Stage1-vs-Stage3 |
7.640000E-01 |
| Stage1-vs-Stage4 |
3.557000E-01 |
| Stage2-vs-Stage3 |
6.932000E-01 |
| Stage2-vs-Stage4 |
8.778200E-01 |
| Stage3-vs-Stage4 |
5.603400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
3.63409968784367E-10 |
| Normal-vs-Asian |
2.34509999974541E-07 |
| Caucasian-vs-AfricanAmerican |
2.646200E-01 |
| Caucasian-vs-Asian |
2.272200E-01 |
| AfricanAmerican-vs-Asian |
1.707230E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
5.31459987129779E-10 |
| Male-vs-Female |
2.062000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.22488694134881E-12 |
| Normal-vs-Extreme_Weight |
1.62536650805123E-12 |
| Normal-vs-Obese |
5.22510035239065E-10 |
| Normal-vs-Extreme_Obese |
1.74710000000466E-06 |
| Normal_Weight-vs-Extreme_Weight |
1.228010E-01 |
| Normal_Weight-vs-Obese |
2.157000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.371200E-01 |
| Extreme_Weight-vs-Obese |
1.637730E-03 |
| Extreme_Weight-vs-Extreme_Obese |
1.438210E-01 |
| Obese-vs-Extreme_Obese |
8.720800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.02900000029405E-08 |
| Normal-vs-Age(41-60Yrs) |
2.22044604925031E-16 |
| Normal-vs-Age(61-80Yrs) |
9.88098491916389E-15 |
| Normal-vs-Age(81-100Yrs) |
3.43780000022775E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.217600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.047000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.624600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.891600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.069000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.965600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62436730732907E-12 |
| Normal-VS-Type2 PRCC |
4.35809999199677E-09 |
| Normal-VS-KIRP CIMP |
2.44929999999588E-05 |
| Normal-VS-Unclassified PRCC |
5.76480000402668E-08 |
| Type1 PRCC-VS-Type2 PRCC |
4.601000E-03 |
| Type1 PRCC-VS-KIRP CIMP |
3.556500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.020750E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.772800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.036400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.106800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.89768209427166E-14 |
| Normal-vs-N1 |
8.14037726115657E-12 |
| Normal-vs-N2 |
3.58560000000008E-05 |
| N0-vs-N1 |
6.906800E-01 |
| N0-vs-N2 |
2.984000E-01 |
| N1-vs-N2 |
9.510400E-02 |
|
|
